TickerFactsScreenerDevelopers

Cardiff Oncology, Inc. (CRDF) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2011: $1.5K2012: $274.1K2013: $649.8K2014: $363.3K2015: $2.24M2016: $823.5K2017: $101.1K2018: $5.1K2019: $67.6K2020: $211.0K2021: $205.0K2022: $1.01M2023: $582.0K2024: $80.0K2025: $44.0K$44.0K
2011Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$44.0K-45.0%
2024$80.0K-86.3%
2023$582.0K-42.1%
2022$1.01M+390.7%
2021$205.0K-2.8%
2020$211.0K+212.0%
2019$67.6K+1225.9%
2018$5.1K-95.0%
2017$101.1K-87.7%
2016$823.5K-63.3%
2015$2.24M+516.9%
2014$363.3K-44.1%
2013$649.8K+137.1%
2012$274.1K+17837.2%
2011$1.5K—